AMBALALSA logo

Ambalal Sarabhai ENT L

AMBALALSA·NSE·
43.80 -0.12 (-0.27%)
Market Cap335.65 Cr
PE Ratio18.88
Volume30,460
Day High - Low44.40 - 42.25
52W High-Low49.98 - 30.15
DocStoX Score
6.1/10
Fair
Fair Value
Sign in to see
ROE
12.40%
Average
P/E
18.88x
Fair
Debt / Equity
0.18
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Fair

Price performance

Day42.25
44.40
52W30.15
49.98
DocStoX take

Supported by growth (8.5) and momentum (7.5), but held back by quality (3.6).

DocStoX score

Low confidence
6.1
/10
Fair
Quality
Modest
ROE 12.4%
Valuation
Fair
P/E 18.9×
Growth
Strong
Revenue +279.0% 3Y CAGR
Risk
Moderate
D/E 0.18
Momentum
Strong
69% of 52-week range

At a glance

Market Cap
₹336 Cr
52W High / Low
₹50 / ₹30
Dividend Yield
0.00%
Promoter Holding
31.36%
EPS (TTM)
₹2.32
Book Value
₹20.70

Key highlights

  • Revenue compounding 279% a year
  • Profit compounding 64% a year
  • Low leverage — D/E 0.18
  • Small ₹336 cr company — thinner liquidity
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

AMBALAL SARABHAI ENT L peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.